| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $96K | — | -29.9% |
| Cost of Revenue | $476K | — | +31.9% |
| Gross Profit | -$380K | — | -69.6% |
| R&D Expense | $311K | — | -10.6% |
| SG&A Expense | $1.5M | — | +8.9% |
| Operating Income | -$2.6M | — | -14.7% |
| Net Income | -$2.5M | — | -29.0% |
| EPS (Basic) | -$0.04 | — | +33.3% |
| EPS (Diluted) | -$0.04 | — | +33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $233K | -60.2% | +61.8% |
| Accounts Receivable | $697K | +40.8% | +182.2% |
| Current Assets | $1.5M | -30.3% | -10.5% |
| Total Assets | $1.5M | -29.9% | -13.0% |
| Current Liabilities | $5.4M | +11.0% | -70.5% |
| Long-term Debt | $176K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.5M | — | +20.8% |
| Capital Expenditures | $2K | — | -60.0% |
| Investing Cash Flow | $352K | — | -81.7% |
| Financing Cash Flow | $838K | — | +991.5% |
| Free Cash Flow | -$1.5M | — | +20.9% |
| -92.5% |
| Total Liabilities | $5.6M | +9.2% | -69.4% |
| Stockholders' Equity | -$4.1M | -37.6% | +75.4% |